Switching from originator infliximab to the biosimilar CT-P13 in 313 patients with inflammatory bowel disease by Viktoria Bergqvist, Mohammad Kadivar, Daniel Molin, Leif Angelison, Per Hammarlund, Marie Olin, Jörgen Torp, Olof Grip, Stefan Nilson, Erik Hertervig, Jan Lillienau, Jan Marsal

Get full text